Product NDC: | 42043-142 |
Proprietary Name: | cephalexin |
Non Proprietary Name: | cephalexin |
Active Ingredient(s): | 125 mg/5mL & nbsp; cephalexin |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42043-142 |
Labeler Name: | Karalex Pharma LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065326 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070712 |
Package NDC: | 42043-142-58 |
Package Description: | 200 mL in 1 BOTTLE (42043-142-58) |
NDC Code | 42043-142-58 |
Proprietary Name | cephalexin |
Package Description | 200 mL in 1 BOTTLE (42043-142-58) |
Product NDC | 42043-142 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cephalexin |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20070712 |
Marketing Category Name | ANDA |
Labeler Name | Karalex Pharma LLC |
Substance Name | CEPHALEXIN |
Strength Number | 125 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |